As con­tro­ver­sy swirls around Cana­di­an drug im­ports, FDA de­bars doc­tor for pur­chas­ing can­cer meds across the bor­der

As a hand­ful of states con­tin­ue to push for con­tro­ver­sial plans to im­port cheap­er drugs from Cana­da — where prices of­ten hov­er at a frac­tion of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA